Home | Welcome to Contract Pharma   
Last Updated Saturday, May 25 2013
Print RSS Feed

Breaking News


April 17, 2012
Could lead to commercial manufacturing of neuraminidase inhibitor  Read More »

April 17, 2012
Mooney to provide global clinical development leadership  Read More »

April 17, 2012
Adds new technology to boost rate, scale of liquid fill  Read More »

April 17, 2012
Will use GPEx technology to express brain cancer treatment  Read More »

April 17, 2012
1Q Revenues: $16.1 billion (flat) 1Q Earnings: $3.9 billion (+12%) Comments: Pharma sales were $6.3 billion, up 1%, with a slight negative impact from currency rates. Consumer sales dropped 2% to $3.6 billion, as the company continues to struggle w…  Read More »
Gil Roth
April 16, 2012
Detreille named senior director  Read More »

April 16, 2012
Deal uses NMR technology to enhance lead discovery, hit identification  Read More »

April 16, 2012
NK-1R antagonist license includes $99 million in milestones  Read More »

April 16, 2012
New line utilizes QbD principles to enhance safety, efficacy  Read More »

April 13, 2012
Laureate CEO brings extensive biopharma industry leadership experience  Read More »

April 13, 2012
ViE Award recognizes pioneers in the vaccines industry  Read More »

April 13, 2012
Special Economic Zone includes global manufacturing facilities  Read More »

April 12, 2012
Lonza to produce commercial material at its facility in the Czech Republic  Read More »

April 12, 2012
Elliot to lead plant remediation strategies and create additional manufacturing capacity  Read More »

April 12, 2012
Biopharma veteran brings 30 years of experience  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On